BBL FIBROMETER 60415 H8292-213413

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 1995-07-14 for BBL FIBROMETER 60415 H8292-213413 manufactured by Becton Dickinson Microbiology.

Event Text Entries

[22187353] Pt was on heparin drip since admission (7/7/95). Continuously monitored by ptt's labwork coagulation levels. Bolus dose was given based on lab values. Clinically demonstrated evidence of multiple hematomas (bleeding). Confirmation received of lab ptt greater than 100 (previously 30-40). Heparin was held and pt was monitored closely with no further evidence of bleeding. Maintained status pain free and hemodynamically stable.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number24324
MDR Report Key24324
Date Received1995-07-14
Date of Event1995-07-09
Date Facility Aware1995-07-10
Date Reported to FDA1995-07-14
Date Added to Maude1995-08-11
Event Key0
Report Source CodeUser Facility report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameBBL FIBROMETER
Generic NamePRECISION COAGULATION TIMER
Product CodeGIE
Date Received1995-07-14
Catalog Number60415 H8292-213413
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Age3 MO
Implant FlagN
Date RemovedB
Device Sequence No1
Device Event Key24689
ManufacturerBECTON DICKINSON MICROBIOLOGY
Manufacturer AddressCOCKEYSVILLE MD 21030 US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 1995-07-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.